Valerio Therapeutics appoints Gilles Besin CEO effective July 2026

• Valerio Therapeutics named Gilles Besin chief executive officer, effective July 2026, replacing Julien Miara.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valerio Therapeutics SA published the original content used to generate this news brief on October 07, 2026, and is solely responsible for the information contained therein.